Over 20 years of C-suite life sciences leadership. Johnny was formerly CEO and CFO of Lamellar Biomedical and also led the spin-out e-Therapeutics plc from Newcastle University and thereafter the raising of over $50 million of investment across 5 investment rounds including taking the company public. He is a chemistry and physics graduate, a chartered accountant with previous experience in IPO, M&A, product development, research projects, product commercialisation as well as patent strategy.
Main navigation
Let's talk
Click below to arrange an informal chat with no obligations.